Science Current Events | Science News | Brightsurf.com
 

Arthritis Current Events | Arthritis News | 4

Sort By: Page Views | Date

Green tea compound may be a therapy for people with rheumatoid arthritis
A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.   view more (2007-04-30)

Gender differences in experience of rheumatism
Rheumatoid arthritis is often a more painful experience for women than it is for men, even though the visible symptoms are the same.   view more (2008-09-15)

Rheumatic disease increases risks in pregnancy, Stanford study finds
The first nationwide study of pregnancy outcomes in women with rheumatic disease confirms that they experience greater pregnancy risks and longer hospital stays than the average pregnant woman.   view more (2005-11-15)

Treating gum disease helps rheumatoid arthritis sufferers
People, who suffer from gum disease and also have a severe form of rheumatoid arthritis, reduced their arthritic pain, number of swollen joints and the degree of morning stiffness when they cured their dental problems.   view more (2009-05-29)

Researchers call for holistic approach in treating rheumatoid arthritis
Researchers have today called for a holistic approach in the management and treatment of patients with rheumatoid arthritis in order to reduce mortality and improve patient outcome. The call for action coincides with the start of EULAR 2001, the prestigious annual congress of the European League Against Rheumatism (EULAR) which opens today... view more... (2001-06-12)

Genetic pathway responsible for link between body clock disturbance and worsening arthritis
The genes that regulate human circadian rhythm, or 'the body clock', are significantly disturbed in individuals with arthritis.   view more (2009-06-11)

Safety claims of new arthritis drugs may be misleading
Popular arthritis drugs, known as selective COX 2 inhibitors, may not be superior to traditional non-steroidal anti-inflammatory drugs, conclude researchers in this week’s BMJ.   view more (2002-05-28)

Inhibiting Proteins May Prevent Cartilage Breakdown in Arthritis Patients
Current arthritis medications can ease the pain, but stopping the progression of the disease requires more aggressive treatments: use of very limited available drugs or surgical intervention. University of Missouri researchers hope to find new therapeutic targets for arthritis by studying the interaction between two proteins that, if interrupted,... view more... (2009-02-19)

Patients with chronic rhinosinusitis have increased incidence of other chronic illnesses
Patients who suffer from chronic rhinosinusitis (CRS) also tend to suffer from other chronic illnesses, like asthma, hypertension, and arthritis.   view more (2009-10-05)

Synthetic protein eases arthritis symptoms in mice
A lab-made version of a human protein alleviates symptoms of both acute and chronic arthritis in mice and could be the basis for a new arthritis drug for people, report scientists from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).   view more (2005-10-04)

Combination drug therapy could substantially improve symptoms of rheumatoid arthritis (pp 670, 675)
The combination of two drugs - both partly effective for rheumatoid arthritis patients when given individually - could be an important development in substantially reducing symptoms and joint destruction for people with rheumatoid arthritis, conclude authors of a study in this week's issue of THE LANCET. Rheumatoid arthritis affects around 1% of... view more... (2004-02-25)

Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis
Infections during the first year of life are a marker of increased risk of developing specific types of arthritis later in life.   view more (2008-06-16)

New trigger for chronic inflammation in rheumatoid arthritis discovered
A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis.   view more (2009-06-29)

Deficiencies In Healthcare Provision Exposed
Serious deficiencies in the healthcare provision for people with arthritis / rheumatism were exposed today in the results of a new European survey.    More than 100 million people in Europe are affected by arthritis / rheumatism, making it Europe's most widespread chronic disease.   The condition can have serious... view more... (2004-06-11)

Immune cells from patients with rheumatoid arthritis have prematurely aged chromosomes
Telomeres, structures that cap the ends of cells' chromosomes, grow shorter with each round of cell division unless a specialized enzyme replenishes them. Maintaining telomeres is thought to be important for healthy aging and cancer prevention.   view more (2009-03-05)

Heavy birthweight increases risk of developing rheumatoid arthritis
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight.   view more (2008-06-30)

Inflammatory disease treatments will improve through the use of lipidomics
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis.   view more (2009-09-02)

Scientists find obesity alone does not cause arthritis in animals
The link between obesity and osteoarthritis may be more than just the wear and tear on the skeleton caused by added weight.    view more (2009-09-29)

Investigational study of ustekinumab in the treatment of psoriatic arthritis published
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).   view more (2009-02-12)

New long-term data suggests Abatacept treatment
New data from the long-term extension of the AIM (Abatacept in Inadequate responders to Methotrexte) trial, announced today at the Annual European Congress of Rheumatology, suggests the selective T-cell co-stimulation modulator abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis patients with an... view more... (2006-06-22)
Sort By: Page Views | Date
© 2009 BrightSurf.com